Condition
Antiviral Treatment
Total Trials
4
Recruiting
0
Active
1
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 15/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
25%
1 trials in Phase 3/4
Results Transparency
100%
1 of 1 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
3Total
Early P 1 (1)
P 1 (1)
P 4 (1)
Trial Status
Unknown2
Completed1
Active Not Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT05381454Phase 1Completed
An Open Label Study in Adults to Test the Efficacy of Mitoquinone/Mitoquinol Mesylate to Prevent Severe Viral Illness
NCT06535048Active Not Recruiting
Impact of Fatty Liver on Hepatitis B Therapy
NCT04507607Early Phase 1Unknown
Efficacy and Safety of TAF in Pregnant Women With Chronic Hepatitis B Infection
NCT02463019Phase 4Unknown
Roll-over After 3-year Trial for Tenofovir in Mild Chronic Hepatitis B
Showing all 4 trials